Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record.

Nuclear Receptor Modulation for the Treatment of Nonalcoholic Fatty Liver Disease

Fuchs, Claudia, Traussnigg, Stefan, Trauner, Michael · 2016 · Seminars in Liver Disease

Abstract

Nuclear receptors (NRs) are ligand-activated transcriptional regulators of several key metabolic processes including hepatic lipid and glucose metabolism, bile acid homeostasis, and energy expenditure as well as inflammation, fibrosis, and cellular proliferation in the liver. Dysregulation of these processes contributes to the pathogenesis and progression of nonalcoholic fatty liver disease (NAFLD). This places NRs at the forefront of novel therapeutic approaches for NAFLD. Some NRs are already pharmacologically targeted in metabolic disorders such as hyperlipidemia (peroxisomal proliferator-activated receptor α [PPARα], fibrates) and diabetes (PPARγ, glitazones) with potential applications for NAFLD. Other NRs with potential therapeutic implications are the vitamin D receptor (VDR) and xenobiotic sensors such as constitutive androstane receptor (CAR) and pregnane X receptor (PXR). Further new perspectives include combined ligands for NR isoforms such as PPARα/δ ligands. Other novel key players represent the nuclear bile acid receptor farnesoid X receptor (FXR; targeted by synthetic FXR ligands such as obeticholic acid) and RAR-related orphan receptor gamma two (RORγt). In this review the authors provide an overview of the preclinical and clinical evidence of current and future treatment strategies targeting NRs in metabolism, inflammation, and fibrogenesis of NAFLD.

Overview

Integrity signals

Registry

Crossref · 10.1055/s-0036-1571296

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 107

Metadata

Authors
Fuchs, C., Traussnigg, S., & Trauner, M.
Affiliations
Medical University of Vienna (AT)
Corresponding author
Trauner, Michael
Venue
Seminars in Liver Disease
Published
2016-02-12
Volume
36
Issue
01
Pages
069-086
ISSN
  • 0272-8087 (ISSN-L)
  • 1098-8971
OpenAlex
W2286534347
Cited by
100
References
0
Citations by year
2026: 1 · 2025: 3 · 2024: 10 · 2023: 7 · 2022: 11 · 2021: 17 · 2020: 10 · 2019: 7 · 2018: 15 · 2017: 11 · 2016: 8
FWCI
12.79
Type
journal article
Language
en
Open access
closed
Locations
  • Seminars in Liver Disease (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Universidad de Chile
  • Pontificia Universidad Católica de Chile
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Keywords
nuclear receptors, non-alcoholic fatty liver disease, PPARα, PPARγ, vitamin D receptor, constitutive androstane receptor, pregnane X receptor, farnesoid X receptor, obeticholic acid, RORγt, hepatic lipid metabolism, hepatic glucose metabolism, bile acid homeostasis, liver inflammation, liver fibrosis
MeSH terms
Animals, Anti-Inflammatory Agents, Humans, Liver, Liver Cirrhosis, Signal Transduction, Treatment Outcome, Receptors, Cytoplasmic and Nuclear, Molecular Targeted Therapy, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nuclear Receptor Modulation for the Treatment of Nonalcoholic Fatty Liver Disease. https://app.cochat.ai/papers/10.1055/s-0036-1571296
The paper
Fuchs, C., Traussnigg, S., & Trauner, M. (2016). Nuclear Receptor Modulation for the Treatment of Nonalcoholic Fatty Liver Disease. Seminars in Liver Disease. https://doi.org/10.1055/s-0036-1571296

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.